Contract Validation
Validate Formulary and Medical Benefit Contract Positions at Scale to Reduce Rebate Leakage
- Reduce Costs with Automated Formulary and Benefit Verification: Eliminate manual formulary and medical benefit verification to streamline rebate processing workflows and improve operational efficiency.
- Access Real-Time Violation Reports and Documentation: View up-to-date violation reports, supporting documentation, and historical analyses directly within the platform for faster, data-driven decisions.
- Leverage Industry-Leading Coverage Data Sources: Access comprehensive formularies and medical policies from a trusted, industry-leading source for accurate coverage and reimbursement insights.
- Act on Strategic Recommendations for Market Access Optimization: Receive expert-backed recommendations from The Dedham Group to guide next steps, improve contract performance, and optimize market access strategy.
Protect Revenue with Accurate Contract Validation
What Our Clients Are Saying
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
"For rare diseases, traditional labs and claims data alone haven’t given us the depth we need to act. Norstella’s EMR data is changing that. The level of clarity is redefining how we go to market."
Director, Commercial and Medical IT, Rare Disease
Global Biotech Company
How We Can Help
MMIT automates the contract validation process by cross-checking formulary and medical benefit requirements against its industry-leading, comprehensive coverage data. This ensures accurate reimbursement, reduces rebate leakage, and helps organizations maintain alignment between payer contracts and real-world coverage policies.
Contract Validation helps your team identify and reduce rebate leakage by automating formulary and medical‑benefit contract verification at scale and cross‑checking requirements against robust, real‑time coverage data to prevent incorrect rebate payments.
Contract Validation ensures payer contracts are executed as agreed by validating formulary and medical‑benefit positioning against industry‑leading coverage documents and surfacing real‑time violation reports with supporting documentation.
Contract Validation improves revenue and contract performance by minimizing manual errors, increasing verification efficiency, and protecting millions in potential losses through accurate, automated contract adherence checks.
Key Insights From MMIT
How Is MMIT’s Contract Validation Solution Helping Pharma Manufacturers?
Hear from pharmaceutical companies already using Contract Validation about how the solution has changed their workflow.
How to Stop Losing Money Due to Inefficient Formulary Verification
Contracting in pharma has grown increasingly complex, which results in significant rebate leakage for manufacturers. Recent MMIT research highlights the severity of the problem.
Solutions to Support Your Strategy
Enhance Contract Validation with integrated solutions that strengthen visibility into formulary alignment, coverage verification, and payer policy changes. By unifying real time contract and coverage intelligence, your team can move from manual review to confident, compliant, data driven action.
Analytics
As the leading platform for pharma market access teams, MMIT Analytics analyzes comprehensive formulary, policy and restriction information to evaluate patient access for your brands, competitors and analogs.